Emily Peterson Alva

Emily Peterson Alva, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alkermes plc. and Amneal Pharmaceuticals, Inc. The record holds 13 filings, for trades running from 6 May 2021 to 5 May 2025.

The open-market side counts 1 purchase for €42k alongside 1 sale for €670k. On balance, insiders were net sellers of €628k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 11 option exercises. Since January 2025: no purchases and 1 sale on the market.

The record was last updated on 8 May 2025 with an option exercise in Amneal Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,881 days ago, on 24 August 2021. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.